ArticleInternational journal of clinical and experimental medicine2015
Effects of CD14 and TLR4 on LPS-mediated normal human skin fibroblast proliferation.
Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 8 citations in OpenAlex.
- Low-dose lipopolysaccharide pretreatment enhanced the proliferation and antibacterial activity of human adipose-derived mesenchymal stem cells.Regenerative therapy · 2026Article
- Adhesion Behaviour of Primary Human Osteoblasts and Fibroblasts on Polyether Ether Ketone Compared with Titanium under In Vitro Lipopolysaccharide Incubation.Materials (Basel, Switzerland) · 2019Article
- Role of Mitogen-Activated Protein Kinases in the Formation of Hypertrophic Scar with Model of Lipopolysaccharide Stimulated Skin Fibroblast Cells.Pakistan journal of medical sciencesArticle
- Epidermal growth factor effect on lipopolysaccharide-induced inflammation in fibroblasts derived from diabetic foot ulcer.Scars, burns & healingArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study was designed to elucidate the effects of CD14 and TLR4 on the proliferation of LPS-mediated normal human skin fibroblasts and to gain new insights into the mechanisms underlying LPS-induced scar formation.
methodsCell morphology and density were observed using an inverted microscope. Proliferation curves were described by MTT. The number of proliferating cells was counted by staining the cells with trypan blue. Cells were stained with propidium iodide (PI) and the phase of cell generation cycle was determined by flow cytometry.
resultsThe growth rate detected in groups B, C, D was slower compared to group A after 48 h. All proliferation curves were approximately S shaped and the peak was seen on days 6, followed by a sharp decline on days 7. The proliferation rate of groups B, C, D was significantly slower than group A. After the staining, we found a significantly smaller number of proliferating cells in groups B, C, D as compared to group A. Flow cytometry revealed that the ratio of proliferating cells at S phase was lower in the groups B, C, D as compared to group A.
conclusionsBoth separate and combined use of anti-CD14 and anti-TLR4 enable a significant decline in the rate and capacity of proliferation, with the latter pretreatment resulting in the sharpest reduction. Therefore, it seems likely that anti-CD14 along with anti-TLR4 is significantly engaged in the signaling mechanisms of LPS-mediated fibroblast proliferation.
Indexed as
Identifiers
25932161PMC4402808W2399971420What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.